Diagnosis is most common in those with recurrent respiratory infection and poor weight gain in the first year of life
Those not diagnosed as newborns may present later in life with more subtle, but troublesome, respiratory infection
CF is a clinical diagnosis, supported by an abnormal sweat chloride level on sweat testing
Genetic analysis may help confirm a diagnosis of CF, but the very large number of mutations now identified make some genotype/phenotype relationships difficult to predict
Newborn screening programmes generally test for raised immune reactive trypsin (IRT) on blood taken within the first week of life, with a subsequent test for CF gene mutations if IRT is elevated
Patients with CF require regular review by health professionals trained in CF care
Patients with CF may inadvertently share respiratory organisms and consideration should be given as how to minimize this risk during hospital contact
Annual review is an important event in the care of patients with CF, enabling a multidisciplinary perspective on the rate of disease progression and plans made to slow this decline
Transition to adult services should begin in early teens, actively involve patients and parents, and provide plenty of opportunity for transfer of information across teams
Current Therapies (2008): In this video, Dr Gill explains how improvements in conventional treatments for CF have greatly improved the level of care available for people with the disease. More...